OWC Pharmaceutical Research Corp. — key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2018)

-$10.3M

Total Assets (FY2018)

$3.6M

Total Equity (FY2018)

-$9.4M

Cash Flows from Operating Activities (FY2018)

-$2.5M

Source: OWC Pharmaceutical Research Corp. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.